Research Grants
Accelerate Brain Cancer Cure (ABC2) has awarded over $14 million to fund brain cancer research. ABC2 invests in each stage of the therapeutic development pipeline. Our Pre-Clincial Screening Program breaks down barriers to entry, our Research Grants focus on novel therapies, and our investments with companies allow us to bring the most promising treatments to patients quickly.
Investments
Many of the greatest advances in science and medicine have been driven by an “entrepreneurial” spirit, and ABC2 believes that a sense of entrepreneurism can continue to be a powerful force in advancing brain cancer research. In order to encourage companies to develop new therapies, ABC2 invests in early stage clinical work in order to test whether a particular drug might be effective in treating brain cancer. ABC2’s investments are designed to accelerate clinical trials and catalyze further investments to bring more effective treatments to patients. Using this approach, in partnership with Genentech, ABC2 was able to demonstrate Avastin effectiveness in treating brain cancer. In 2009, beyond our academic research grants, ABC2 invested in three companies each of which hold the potential to dramatically improve patient care. Read more.
Annual Scientific Meeting
ABC2 hosts an annual scientific meeting to give researchers, investors, policy leaders, and industry leaders the chance to discuss progress in brain cancer research. The meeting serves as a catalyst for innovation and allows scientists to form collaborations with biotechnology and pharmaceutical companies that can drive discoveries from lab to the clinic.
Share Your Research Ideas
We believe innovation and solid research should not linger in research labs. Our research funding process is designed to move the best ideas into the clinic as soon as possible. We look for proposals which identify a clear problem and layout a clear roadmap to find a solution. Please share your research idea with ABC2.
